Additionally, although alterations of other immune populations in the tumor microenvironment were observed following DP therapy, such as CD4+ T cells (Supplemental Figure 18), the detailed regulation mechanism as well as the interplay between distinct immunocytes were undetermined. This evidence concerns the gene CD4 and neoplasm.